Conference on Over-the-Counter 2009

Jan. 8, 2009 - PRLog -- Conference on Over-the-Counter 2009                    

To be held at 2nd - 3rd March 2009, London, UK

Background Info
Since the introduction of the first "over-the-counter" (OTC) review in 1972, OTC drugs have played a major role in the global pharmaceutical industry. As drug sponsors have sought to expand the OTC market with self-care therapeutics, much of the interest has centered on what is required of both a product and a product’s sponsor before a switch from Rx(prescription) to OTC can occur. This has led to an ever-changing environment where Rx-to-OTC switches are concerned, these changes are driven by drug manufacturers, the governing bodies themselves and in some landmark cases a third party healthcare provider.

The increasing cost of Rx medicines to payer groups (health insurers and governments) has resulted in payer groups encouraging self medication with OTC products. Future growth in the OTC market will also be driven by the increasing numbers of retailers looking to sell their own "home brand" OTC products in order to obtain high retail margins- Consumers demands for easy access, low cost, effective products and their increasing knowledge of medicines are important drivers of future OTC switching activity.

Well-known OTC brands are a familiar sight in our pharmacies and retail outlets. They provide a first line of defence for numerous consumers against minor ailments and injuries and are one of the most visible faces of the pharmaceutical industry. In 2007 the world market for OTC pharmaceuticals generated sales of US $85bn, an increase of 4% from the 2006 figure of $82bn.(Visiongain Report 2008) The OTC market is hot and dynamic and expanding at such a rate that every pharmaceutical company wants to be the leading brand. Visongain’s Over-the-Counter Conference 2009 will address what methods are being used to create brand loyalty which is driven by necessity and emotional belief.

Leading therapeutic area for the worldwide OTC industries are:
• Analgesics
• Cough, cold & allergy
• Gastrointestinal
• Medicated skincare
• Vitamins, minerals & supplements
• Sleeping/Calming

The world market for OTC pharmaceuticals will almost double in size by 2023 and with the demand being high, the race to be the number one brand in the over-the-counter has already started.

Reasons why you will not want to miss out:
Key Themes:
1. Discover recent developments to stop the counterfeiting of all drugs worldwide, which is undermining the industry’s market integrity
2. The importance of medicines labelling and packaging design, leading to improved patient safety and brand loyalty and examine consumers behaviour
3. The continuing trends towards increased sales of the “over-the-counter” products by mail-order and web-based pharmacies
4. Superstores wanting to cash in on the benefits of “over-the-counter” boom- Who are the leading retailers and what are the innovations that are required to be a recognised player
5. Who are the leading global “over-the-counter” pharmaceutical manufactuers are and what steps are being taken to keep the positions- The bar has been raised!
6. Meeting the demands of the consumer expectations-they hold the key to future success. Brand loyalty is the “over the counter” Holy Grail.

Key Speakers
• Marnix T Artz, Manager Key Customs Relations, Patent Advocacy, Pfizer
• Anne-Toni Rodgers, Director, Government Affairs and Public Policy Europe, Baxter
• Dr Philip Berry, Global Medical Director, Reckitt Benckiser Healthcare International
• Dr Harvinder Popli, Director and Head In- Licensing, Ranbaxy Labs
• Alex Gourlay, Managing Director, Boots
• Bert Oosting, Advocate, Lovells
• Max Vetter, Manger, ICC Counterfeiting Intelligence Bureau
• Prof. John Weinman, Atlantis Healthcare UK
• John Gill, Chief Scientist, Royal National Institute of the Blind

Who will be there? Companies:
• Pharmaceutical and Biotech Companies
• Pharmacies/ Pharmacy Chains
• Regulatory Research Organisations
• Trade Organisations
• Healthcare Professionals
• Hospitals
• Retail Outlets
• Wholesale Distribution

VPs, Directors, Consultants and Management of:
• New Product Global Marketing
• Licensing and Partnership
• Business Development
• Drug Development
• Regulatory Affairs
• Marketing and Advertising
• Clinical Developments
• Project Leaders
• Medical Informatics
• Education Programs
• Global Scientific Affairs
• Outcomes research
• Therapeutic Area
• International Economic Strategy
• Drug Safety/ Pharmacovigilance
• Retail outlets

For more information kindly visit
http://www.bharatbook.com/Market-Research-Reports/Confere...

OR Contact us at

Bharat Book Bureau
207, Hermes Atrium, Sector 11, PO Box.54, CBD Belapur, Navi Mumbai - 400 614, India.
Phone : +91 22 2757 8668 / 2757 9438
Fax : +91 22 2757 9131
E-mail : info@bharatbook.com
Website : www.bharatbook.com